期刊文献+

重型β珠蛋白生成障碍性贫血患儿生长发育指标与血清铁蛋白、血红蛋白量的关系和意义 被引量:4

Relationship and Significance of Serum Ferritin,Pretransfusion Mean Hemoglobin and Upgrowth Index in Children with β Thalassemia Major
原文传递
导出
摘要 目的了解重型β珠蛋白生成障碍性贫血(简称β地贫)患儿生长发育指标落后情况,以及血清铁蛋白(SF)定量、每次输血前Hb量对其生长发育指标的关系和意义。方法对59例重型β地贫(地贫组)患儿和48例同龄健康儿童(健康对照组)检测生长参数:身高[计算身高标准差分值(SDS)]、体质量[计算体质量指数(BMI)],Hb量、SF定量,青春发育分期采用Tanner分期方法分期。应用SPSS11.0软件进行统计学分析。结果与对照组比较,重型β地贫患儿组身高SDS、Hb量、SF定量水平均显著降低(t=-7.084,-25.771,11.928Pa<0.01),而BMI无显著性差异(t=-0.326P>0.05)。青春期发育程度中,在重型β地贫组(10~14岁)21例患儿中仅2例开始发育,且均为Tanner2期,而对照组(10~14岁)24例中全部开始正常发育,重型β地贫患儿发育显著落后。患儿身高SDS与年龄呈显著负相关(r=-0.588P<0.01),与每次输血前Hb呈正相关(r=0.219P<0.05),与SF无相关性(r=0.033P>0.05)。结论重型β地贫的生长和发育指标均落后于正常同龄儿,年龄越大,落后越明显。其生长发育异常与患儿体内铁超负荷有关。患儿平时保持Hb水平相对高值,正规采用去铁胺等祛铁治疗将有助于改善患儿最终身高和发育水平。 Objective To investigate the relationship and significance of serum ferritin( SF), pretransfusion mean hemoglobin (Hb) and upgrowth index in children with β thalassemia major. Methods Fifty - nine children with β - thalassemia major and 48 healthy children ( control group), ranging in age from 2 years and 9 months to 14 years were studied. Height and weight were measured and standard deviation scores (SDS) and body mass index (BMI) were calculated according to local standards. SF and pretransfusion mean Hb were measured. The stages of adolescence was used by stages as Tanner method. The correlation analysis was used as statistical method with SPSS 11.0 software. Results Height SDS, pretransfusion mean Hb and SF in children with β - thalassemia major were significantly lower than those in control group(t= -7.084, -25.7.71,11.928 Pa 〈0.01). While BMI had no significance (t = -0. 326 P〉0.05). Only 2 children with β - thalassemia major (aged 10 - 14 years, n = 21 )were pubescent. The control group (aged 10 - 14 years,n = 24)were pubescent. The upgrowth of children was significantly behinder than in control group. Height SDS was negative correlated with age ( r = - 0. 588 P 〈 0. 01 ). Height SDS was positive correlated with mean pretransfusion Hb ( r = 0. 219 P 〈 0.05 ). There was no significant correlation between height SDS and ferritin levels ( r = 0. 033 P 〉 0.05 ). Conclusions The index and development of upgrowth in children with β thalassemie children were lower than normal children. These changes were much more obvious with ages. This may be related with iron overload. Maintaining the higher Hb lever and alleviating iron overload may be required to obtain an improvement in upgrowth in β - thalassemie children.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2009年第3期196-197,222,共3页 Journal of Applied Clinical Pediatrics
关键词 Β珠蛋白生成障碍性贫血 身高标准差分值 血清铁蛋白 血红蛋白 β- thalassemia height standard deviation scores serum ferritin hemoglobin
  • 相关文献

参考文献11

  • 1张堵,李辉.正常小儿的体格发育标准[M]//胡亚美,江载芳.诸福棠实用儿科学.7版.北京:人民卫生出版社.2002:19-38.
  • 2王慕逖.正常的生长和发育[M]//颜纯,王慕逖.小儿内分泌学.2版.北京:人民卫生出版社,2006:78-80.
  • 3黄钰君,伍绍国,区小冰,张力,余一平.儿童地中海贫血的发生率及发病基因分析[J].中国优生与遗传杂志,2007,15(6):28-31. 被引量:35
  • 4Low LC. Growth of children with beta - thalassemia major[ J]. Indian J Pediatr,2005,72 ( 2 ) : 159 - 164.
  • 5Lasco A, Morabito N, Gaudio A, et al. Osteoporosis and beta - thalassemia major: Role of the IGF - I/IGFBP - Ⅲ axis[J]. J Endocrinol Invest,2002,25 (4) :338 - 344.
  • 6Vidergor G, Goldfarb AW, Glaser B, et al. Growth hormone reserve inadult beta thalassemia patients [ J ]. Endocrine,2007,31 ( 1 ) :33 - 37.
  • 7周雪贞,张美芬,林岩,刘可.重型地中海贫血患儿治疗依从性状况调查[J].护理研究(上旬版),2008,22(2):308-310. 被引量:9
  • 8Ozkan A, Arslanoglu I, Yoruk A, et al. Evaluation of growth hormone secretion and insulin - like growth factor I in children with thalassemia [J]. Indian Pediatr ,2001,38( 5 ) :534-539.
  • 9Au WY, Lam WW, Chu WW, et al. A cross - sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong [ J ]. Haematologica, 2008,93 ( 5 ) : 784 - 786.
  • 10Toumba M, Sergis A, Kanaris C,et al. Endocrine complications in patients with Thalassemia Major [ J ]. Pediatr Endocrinol Rev, 2007,5 (2) :642 -648.

二级参考文献19

  • 1符忠佩,张建江.急性淋巴细胞白血病患儿心理干预研究[J].临床心身疾病杂志,2004,10(4):264-265. 被引量:12
  • 2周达生,姚华庭.医学系统工程与遵医行为研究[J].中国医院管理,1995,15(2):37-39. 被引量:583
  • 3文朝阳,尤黎明,谭坚铃,陈秀云,梁卫萍,覃惠英.有肝癌家族史肝癌高危人群监查依从性及其影响因素分析[J].解放军护理杂志,2005,22(9):28-30. 被引量:7
  • 4曾瑞萍,胡彬,金龙金.广东地区血红蛋白H病基因型分析及高危胎儿基因诊断[J].中华医学遗传学杂志,1996,13(5):266-268. 被引量:69
  • 5杜传书.地中海贫血研究的现状与未来[J].中华医学遗传学杂志,1996,13(5):257-257.
  • 6张之南,杨天楹,郝玉书,主编,血液病学[M].第一版.北京:人民卫生出版社,2003.521.
  • 7Xu XM,Zhou YQ,Luo GX,et al.The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province:implications for the future health burden and population screening[J].J Clin Pathol,2004 May,57(5):517.
  • 8Lau YL,Chan LC,Chan YY,et al.Prevalence and genotypes of alpha-and beta-thalassemia carriers in Hong Kong -implications for population screening[J].N Engl J Med,1997 May 1,336(18):1298.
  • 9Tamagnini GP,Kuam B,Fai WK.Congenital anemias in Macao[J].Hemoglobin,1988,12(5-6):637.
  • 10Xu X,Liao C,Liu Z,et al.Antenatal screening and fetal diagnosis of beta-thalassemia in a Chinese population:prevalence of the beta-thalassemia trait in the Guangzhou area of China[J].Hum Genet,1996 Aug,98(2):199-202.

共引文献42

同被引文献18

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部